Search

everythinglearnresearchcommunity

for

Search:↓

Blocking GPR91 can help prevent and reverse hair loss in androgenetic alopecia.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Scalp fungi and sebum differences may affect hair loss in men.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

Folliculotropic mycosis fungoides can look like alopecia areata.

A person with thyroid problems had rare, swollen, bald spots on their scalp caused by a condition usually found on the shins.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Atypical male hair loss may not respond to usual treatments.

Garlic gel can help hair grow in people with alopecia areata.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Hair disorders include hair loss, excessive hair growth, and ingrown hairs, with various treatments available depending on the cause.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.